IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.664
NA - Nord America 20.593
AS - Asia 17.792
Continente sconosciuto - Info sul continente non disponibili 2.521
SA - Sud America 1.900
AF - Africa 495
OC - Oceania 272
Totale 65.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.467
GB - Regno Unito 5.966
IT - Italia 5.610
CN - Cina 5.421
SG - Singapore 4.544
DE - Germania 2.846
BD - Bangladesh 1.520
RU - Federazione Russa 1.448
HK - Hong Kong 1.389
VN - Vietnam 1.284
BR - Brasile 1.255
SE - Svezia 1.248
FR - Francia 1.016
CA - Canada 754
IN - India 739
JP - Giappone 664
IE - Irlanda 638
NL - Olanda 580
FI - Finlandia 495
ES - Italia 485
TR - Turchia 458
KR - Corea 454
ID - Indonesia 393
UA - Ucraina 270
AU - Australia 221
CO - Colombia 185
MX - Messico 177
TW - Taiwan 171
DK - Danimarca 154
AR - Argentina 140
CI - Costa d'Avorio 132
BE - Belgio 130
CH - Svizzera 129
AT - Austria 117
GR - Grecia 113
TH - Thailandia 112
EU - Europa 110
ZA - Sudafrica 99
IQ - Iraq 98
PL - Polonia 95
CL - Cile 78
EC - Ecuador 77
PK - Pakistan 70
SA - Arabia Saudita 70
PE - Perù 65
PH - Filippine 54
PT - Portogallo 49
RO - Romania 47
IR - Iran 44
NZ - Nuova Zelanda 44
EG - Egitto 43
MY - Malesia 40
VE - Venezuela 40
UZ - Uzbekistan 36
CR - Costa Rica 32
IL - Israele 32
MA - Marocco 32
BO - Bolivia 31
JM - Giamaica 30
DZ - Algeria 29
NO - Norvegia 28
JO - Giordania 26
KE - Kenya 26
TN - Tunisia 24
ET - Etiopia 23
HU - Ungheria 23
LT - Lituania 23
LU - Lussemburgo 23
CZ - Repubblica Ceca 21
DO - Repubblica Dominicana 19
AE - Emirati Arabi Uniti 18
LB - Libano 18
MD - Moldavia 18
TT - Trinidad e Tobago 18
HN - Honduras 16
NP - Nepal 16
PY - Paraguay 15
RS - Serbia 15
BG - Bulgaria 13
KZ - Kazakistan 13
NG - Nigeria 13
PA - Panama 13
AZ - Azerbaigian 11
BB - Barbados 11
NI - Nicaragua 11
PR - Porto Rico 11
SN - Senegal 11
SV - El Salvador 11
UY - Uruguay 11
OM - Oman 10
PS - Palestinian Territory 10
SC - Seychelles 10
AL - Albania 9
BH - Bahrain 8
EE - Estonia 8
GT - Guatemala 8
QA - Qatar 8
AM - Armenia 7
GE - Georgia 7
MK - Macedonia 7
Totale 62.661
Salva come PNG Salva come JPEG
Città #
Southend 5.139
Singapore 2.641
Ashburn 2.162
Milan 1.303
Hong Kong 1.234
Chandler 1.118
Hanover 1.087
San Jose 1.049
Fairfield 1.032
Council Bluffs 876
Beijing 844
Wilmington 679
Princeton 660
Seattle 650
Santa Clara 622
Dublin 617
Dallas 607
Houston 588
Frankfurt am Main 572
Woodbridge 511
Los Angeles 474
Ann Arbor 443
New York 407
Guangzhou 384
Cambridge 367
Ho Chi Minh City 360
Hanoi 331
Toronto 315
Lauterbourg 302
Buffalo 292
Rome 292
Hangzhou 281
Helsinki 265
Tokyo 256
Jakarta 251
Shanghai 251
Des Moines 246
Nanjing 234
Bengaluru 229
Redwood City 227
Moscow 222
Dearborn 207
Jacksonville 200
Boardman 175
Istanbul 169
Munich 155
Barcelona 154
Phoenix 153
Seoul 152
Chicago 136
Abidjan 131
Columbus 130
London 130
San Diego 130
São Paulo 130
Naples 129
Berlin 125
Hefei 125
Redmond 124
The Dalles 118
Cangzhou 113
Turin 113
Tianjin 106
Mountain View 100
Palermo 94
Shenyang 94
Florence 90
Atlanta 89
Jinan 86
Bogotá 80
Paris 79
Bologna 78
Nuremberg 74
Montreal 71
Shenzhen 71
Taipei 71
Zhengzhou 71
Changsha 70
Wuhan 70
Brussels 69
Serra 66
Andover 65
Madrid 64
Athens 61
Hebei 59
Sakarya 59
Nanchang 58
Fuzhou 57
Melbourne 56
Somerville 56
Washington 55
Dong Ket 54
Central District 52
Da Nang 51
Vienna 51
Boston 50
Verona 50
Bangkok 49
Haiphong 48
Philadelphia 48
Totale 35.991
Salva come PNG Salva come JPEG
Nome #
Aspiration risk factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 2.401
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) 1.628
Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients with Bronchiectasis : A Multicenter Cohort Study 1.319
Mapping the human genetic architecture of COVID-19 1.274
The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis 1.260
Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy 713
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 712
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 651
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 638
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 601
Come scrivere un articolo scientifico = How to write a scientific paper 483
The Italian registry of pulmonary non-tuberculous mycobacteria : IRENE: The study protocol 449
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 442
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response 433
Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy 408
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 398
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 395
International perspective on the new 2019 ATS/IDSA CAP guideline - a critical appraisal by a global expert panel 379
A 13-year-old female with shortness of breath and pleuritic chest pain 365
Chest X-ray findings in a large cohort of 1117 patients with SARS-CoV-2 infection: a multicenter study during COVID-19 outbreak in Italy 347
Comparison of different conditions for DNA extraction in sputum : A pilot study 346
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 343
Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19 341
Management of drug toxicity in M. avium complex pulmonary disease - an expert panel survey 338
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 325
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 325
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 322
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema : a multicenter, perspective, observational study for the ACPE SIMEU study group 316
Non-Intensive Care Unit Acquired Pneumonia : A New Clinical Entity? 315
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis 314
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective 313
The biology of pulmonary exacerbations in bronchiectasis 312
Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study 302
Neutrophil elastase in bronchiectasis 299
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy 297
An international perspective on hospitalized patients with viral community-acquired pneumonia 294
Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients 291
100 years of respiratory medicine : Pneumonia 289
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis 284
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 282
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 277
Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review 276
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 270
Chlamydia pneumoniae and Mycoplasma pneumoniae 269
Upper Respiratory Tract Microbiome and Otitis Media Intertalk : Lessons from the Literature 269
Complement activation in patients with COVID-19: a novel therapeutic target 262
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 261
Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia 258
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 258
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study 257
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) 255
COVID-19 multidisciplinary high dependency unit: the Milan model 254
Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155) 253
What is the best technique to extract bacterial DNA from sputum? 252
Hemostatic alterations in COVID-19 249
Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis 248
Azithromycin and lower respiratory tract infections 246
Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis 245
Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques 245
The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients 244
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC) 243
Antibiotic therapy and prophylaxis in COPD 241
Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria 241
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 240
Early detection of deep vein thrombosis in patients with coronavirus disease 2019 : who to screen and who not to with Doppler ultrasound? 240
Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study 235
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 234
Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease : a systematic review and meta-analysis 234
Individualizing duration of antibiotic therapy in community-acquired pneumonia 232
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 229
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients 229
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease : A Cohort of Hospitalized Patients 228
Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling 228
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 227
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 227
Bronchiectasis : an update 226
Bronchiectasis in India : results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry 226
Selection of Candidates for Lung Transplantation : The First Italian Consensus Statement 226
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 225
COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy 225
Pulmonary fibrosis secondary to COVID-19 : a call to arms? 224
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 224
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 223
The ADAMTS13-von Willebrand factor axis in COVID-19 patients 222
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 220
Polmoniti nosocomiali: dalle basi epidemiologiche alla terapia 217
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 217
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 217
Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease 216
STEROIDS ARE NOT ASSOCIATED WITH AN IMPROVEMENT IN CLINICAL OUTCOMES IN HOSPITALISED PATIENTS WITH CAP 214
Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement 211
Microbiological testing of adults hospitalised with community-acquired pneumonia : an international study 210
Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation 210
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicenter, cohort study 210
IN CIDENCE, RISK FACTORS AND OUTCOMES OF CARDIOVASCULAR EVENTS IN HOSPITALISED PATIENTS WITH CAP 207
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 207
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 206
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 205
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis 204
Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience 204
Totale 35.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 176.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.666 0 0 427 338 426 414 821 719 698 520 391 912
2022/20235.604 722 534 444 558 456 981 311 368 514 130 370 216
2023/20244.436 192 335 283 362 771 349 355 264 212 303 465 545
2024/20258.830 460 902 266 840 611 526 450 885 645 738 950 1.557
2025/202618.952 1.449 967 1.702 1.347 1.704 1.286 2.249 1.159 2.037 1.320 1.999 1.733
2026/20272.755 1.191 1.237 327 0 0 0 0 0 0 0 0 0
Totale 65.237